Internal Medicine, Infectious Disease · Honolulu, HI
NPI
1588900468
Since 2012
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1010 S King St, Suite 111
Honolulu, HI, 96814
Phone (808) 597-8765
Groups this clinician bills Medicare through
Medicare paid, 2024
$249K
3,407 services
Medicare patients, 2024
382
Average age 78
Drug cost, 2024
$1.3M
1,668 prescriptions
Company payments, 2025
$1,803
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Takashi Shinha was code 99232 (hospital e&m - subsequent), 2,033 times for 264 patients. In total Takashi Shinha billed 3,407 services in 7 codes, and Medicare paid $249K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 2,033 | 264 | $61.40 | $125K |
| 99214 Office E&M - Established | Office | 813 | 242 | $100.25 | $82K |
| 99222 Hospital E&M - Initial | Facility | 285 | 245 | $98.64 | $28K |
| 99231 Hospital E&M - Subsequent | Facility | 160 | 72 | $38.19 | $6,111 |
| 99214 Office E&M - Established | Facility | 92 | 16 | $71.70 | $6,597 |
| 99233 Hospital E&M - Subsequent | Facility | 20 | 13 | $83.80 | $1,676 |
By year: 2022 $303K for 4,383 services; 2023 $285K for 3,887 services; 2024 $249K for 3,407 services.
Medicare prescription drug claims, 2024
In 2024, the drug Takashi Shinha prescribed most often to Medicare patients was Amoxicillin-Clavulanate Potass (Amoxicillin/Potassium Clav), with 152 prescriptions and refills. In total Takashi Shinha wrote 1,668 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 152 | 159 | 74 | $4,693 |
| Azithromycin Generic | 150 | 178 | 30 | $13K |
| Ethambutol Hcl Generic | 123 | 147 | 28 | $7,148 |
| Ertapenem Ertapenem Sodium | 113 | 113 | 24 | $58K |
| Rifampin Generic | 113 | 133 | 29 | $6,161 |
| Ciprofloxacin Hcl Generic | 77 | 85 | 42 | $2,450 |
| Doxycycline Hyclate Generic | 62 | 62 | 35 | $1,485 |
| Ceftazidime Generic | 59 | 59 | 11 | $6,212 |
| Methenamine Hippurate Generic | 53 | 101 | 17 | $4,211 |
| Arikayce Amikacin Liposomal/Neb.Accessr | 51 | 51 | Under 11 | $791K |
| Vancomycin Hcl Generic | 40 | 40 | Under 11 | $5,158 |
| Minocycline Hcl Generic | 38 | 38 | 21 | $1,749 |
| Atorvastatin Calcium Generic | 34 | 103 | Under 11 | $1,151 |
| Fluconazole Generic | 30 | 33 | 18 | $964 |
| Levofloxacin Generic | 26 | 30 | 12 | $599 |
Brand drugs: - claims; generic drugs: 1,513 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Takashi Shinha $1,803 ($1,803 in general payments such as food, travel and fees) from 9 companies. The largest payer was Insmed, Inc. with $571.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.